Detalhe da pesquisa
1.
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.
N Engl J Med
; 390(10): 875-888, 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38446675
2.
Bladder Cancer, Version 3.2024.
J Natl Compr Canc Netw
; 22(4): 216-225, 2024 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38754471
3.
The JAVELIN Bladder Medley trial: avelumab-based combinations as first-line maintenance in advanced urothelial carcinoma.
Future Oncol
; 20(4): 179-190, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37671748
4.
Diagnosis and Management of Non-Metastatic Upper Tract Urothelial Carcinoma: AUA/SUO Guideline.
J Urol
; 209(6): 1071-1081, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37096584
5.
Comparison of clinicopathological characteristics, gene expression profiles, mutational analysis, and clinical outcomes of pure and mixed small-cell carcinoma of the bladder.
Histopathology
; 82(7): 991-1002, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36754853
6.
Enhancing bladder cancer care through the multidisciplinary clinic approach.
Can J Urol
; 30(3): 11526-11531, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37344462
7.
Four versus 3 Cycles of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: Implications for Pathological Response and Survival.
J Urol
; 207(1): 77-85, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34445890
8.
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022.
J Natl Compr Canc Netw
; 20(8): 866-878, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35948037
9.
Targeting FGFR3 alterations with adjuvant infigratinib in invasive urothelial carcinoma: the phase III PROOF 302 trial.
Future Oncol
; 18(21): 2599-2614, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35608106
10.
Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(4): 525-537, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33721560
11.
Imaging urothelial bladder cancer: A VPAC PET targeted approach.
Can J Urol
; 28(2): 10596-10602, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33872557
12.
Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results.
Cancer
; 126(11): 2597-2606, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32208524
13.
Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma.
J Urol
; 203(4): 690-698, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31702432
14.
Bladder Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 18(3): 329-354, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32135513
15.
Development and evaluation of a bladder Cancer specific survivorship care plan by patients and clinical care providers: a multi-methods approach.
BMC Health Serv Res
; 20(1): 686, 2020 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-32709234
16.
Apatorsen plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial carcinoma (Borealis-2).
Br J Cancer
; 118(11): 1434-1441, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29765151
17.
Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial.
Lancet
; 389(10064): 67-76, 2017 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27939400
18.
Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial.
Lancet
; 387(10031): 1909-20, 2016 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-26952546
19.
Recurrent renal cell carcinoma presenting as a solitary left ventricular mass.
Can J Urol
; 24(6): 9145-9147, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29260644
20.
A Phase I/II Study of the Investigational Drug Alisertib in Combination With Abiraterone and Prednisone for Patients With Metastatic Castration-Resistant Prostate Cancer Progressing on Abiraterone.
Oncologist
; 21(11): 1296-1297e, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28178640